MacroGenics Interest Expense 2011-2026 | MGNX

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense MacroGenics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.43 M	1.66 M	680 K	1.32 M	25.4 M	-247 K	2.52 M	1.51 M	42 K	2 K	-627 K	157 K	1.47 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
25.4 M	-627 K	2.71 M

Quarterly Interest Expense MacroGenics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
3.34 M	802 K	91 K	-	-	6 K	1.13 M	-	-	774 K	-	-	142 K	504 K	195 K	-	101 K	344 K	21 K	-	92 K	425 K	721 K	-	-6.69 M	21.2 M	2.6 M	-	975 K	1.07 M	674 K	-	681 K	525 K	553 K	-	419 K	370 K	270 K	-	1 K	-86 K	-3 K	-	-	1 K	-	-	-554 K	-40 K	-34.2 K	-	1.56 K	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
21.2 M	-6.69 M	875 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Autolus Therapeutics plc AUTL	9.29 M	$ 1.99	1.02 %	$ 508 M	Britain
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
Aclaris Therapeutics ACRS	2.95 M	$ 3.01	3.79 %	$ 233 M	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Alterity Therapeutics Limited ATHE	2.28 K	$ 3.08	0.65 %	$ 7.41 B	Australia
AlloVir ALVR	1.19 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	-5.01 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	-4 K	-	-	$ 10.1 M	USA
Alpine Immune Sciences ALPN	476 K	-	-	$ 2.17 B	USA
Avenue Therapeutics ATXI	294 K	-	-52.27 %	$ 4.45 M	USA
Aeglea BioTherapeutics AGLE	-20.7 M	-	-	$ 1.01 B	USA
BioVie BIVI	4.3 M	$ 1.16	2.65 %	$ 1.71 M	USA
Ascendis Pharma A/S ASND	65.5 M	$ 213.24	1.87 %	$ 5 B	Danmark
BioDelivery Sciences International BDSI	-6 K	-	-4.8 %	$ 255 M	USA
Catalyst Biosciences CBIO	1.04 M	$ 11.86	2.24 %	$ 781 M	USA
Athersys ATHX	103 K	-	3.77 %	$ 22.4 M	USA
Certara CERT	-15.5 M	$ 8.81	-0.56 %	$ 1.41 B	USA
Celldex Therapeutics CLDX	927 K	$ 27.16	2.76 %	$ 1.75 M	USA
Cellectis S.A. CLLS	371 K	$ 4.84	1.26 %	$ 116 M	France
ARCA biopharma ABIO	9 K	-	1052.0 %	$ 415 M	USA
Bellicum Pharmaceuticals BLCM	2.66 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	910 K	-	-7.31 %	$ 87 M	USA
Adaptimmune Therapeutics plc ADAP	-807 K	-	-15.15 %	$ 60.3 M	Britain
bluebird bio BLUE	16.4 M	-	-	$ 546 M	USA
Albireo Pharma ALBO	3.69 M	-	-0.23 %	$ 916 M	USA
Can-Fite BioPharma Ltd. CANF	227 K	$ 0.2	8.46 %	$ 435 M	Israel
Amphastar Pharmaceuticals AMPH	4.08 M	$ 26.78	-0.81 %	$ 1.3 B	USA
BeiGene, Ltd. BGNE	-12.6 M	-	0.49 %	$ 251 B	Cayman-islands
CorMedix CRMD	34.3 K	$ 11.63	-6.81 %	$ 592 M	USA
Calithera Biosciences CALA	2.65 M	-	-10.95 %	$ 876 K	USA
Arena Pharmaceuticals ARNA	4.16 M	-	-6.81 %	$ 3.04 B	USA
Acer Therapeutics ACER	432 K	-	2.71 %	$ 14 M	USA
Axon Enterprise AXON	286 M	$ 567.93	-0.73 %	$ 43 B	USA
Aytu BioScience AYTU	-512 K	$ 2.6	1.96 %	$ 16.3 M	USA
Acorda Therapeutics ACOR	31.5 M	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	5 K	-	-5.38 %	$ 6.06 M	USA